Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 220
Keywords: Prognosis
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Available to PurchaseSubject Area:
Oncology
Khanh Van Nguyen, Kosuke Matsui, Hisashi Kosaka, Hideyuki Matsushima, Hidekazu Yamamoto, Tung Thanh Lai, Kyoko Inoue, Moriyasu Takada, Fujimasa Tada, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Hiroki Kato, Kengo Yoshii, Takashi Yamaguchi, Shinji Shimoda, Makoto Naganuma, Masaki Kaibori
Journal:
Oncology
Oncology (2025)
Published Online: 28 March 2025
... to in the content or advertisements. 2025 Atezolizumab Bevacizumab Cachexia Hepatocellular carcinoma Prognosis Globally, hepatocellular carcinoma (HCC) ranks sixth among the most prevalent malignant cancers, but fourth in terms of cancer-related mortality [ 1 ]. In early-stage HCC, treatment...
Journal Articles
Subject Area:
Oncology
Alberto Guijosa, Luis Antonio Cabrera-Miranda, Ana Pamela Gómez-García, Rogelio Trejo Rosales, Wendy Muñoz-Montaño, Diana Flores, Nancy Reynoso-Noverón, Oscar Arrieta
Journal:
Oncology
Oncology (2025)
Published Online: 11 March 2025
... Mesothelioma Prognosis Survival Chemotherapy Latin America Pleural mesothelioma (PM) is a rare, yet highly aggressive cancer originating from the mesothelial lining of the pulmonary pleura, notorious for its poor prognosis. Although the precise global impact of mesothelioma remains uncertain...
Journal Articles
Significance of TYMS Polymorphism rs3819102 as a Prognostic Marker for Nonsmoking Lung Cancer Patients of the Han Ethnicity in China
Available to PurchaseSubject Area:
Oncology
Wei Du, Chang Xu, Zhiyuan Cheng, Zhenyu Sun, Shicheng Guo, Qiang Li, Yuanlin Song, Bo Shen, Yang Bao, Junjie Wu
Journal:
Oncology
Oncology (2025)
Published Online: 29 January 2025
..., and predicting the prognosis of lung cancer patients and using it to develop treatment strategies and interventions is important for prolonging the survival time of patients. Folate metabolism involves various aspects such as methylation of DNA, RNA, proteins, lipids, etc. Disorders of folate metabolism...
Journal Articles
High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
Available to PurchaseSubject Area:
Oncology
Yasunori Matsumoto, Ryota Otsuka, Yuri Nishioka, Takeshi Toyozumi, Nobufumi Sekino, Tadashi Shiraishi, Koichiro Okada, Toshiki Kamata, Shinichiro Iida, Hiroki Morishita, Tenshi Makiyama, Masanari Yamada, Hisahiro Matsubara
Journal:
Oncology
Oncology (2025)
Published Online: 27 January 2025
... of the poorest cancer prognosis rates; there is an urgent need to develop new drug therapies and biomarkers. CD63, a tetraspanin protein and well-known exosomal marker, is implicated in cancer progression; however, the significance of CD63 expression in ESCC remains unclear. Herein, we report the significance...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology 591–609.
Published Online: 16 October 2024
... to immunotherapy were analyzed by survival analysis, immune infiltration analysis, and immunotherapy response analysis. Results: We have developed a risk signature model based on eight key immune-related genes, which can classify patients into high-risk and low-risk groups. The prognosis of the high-risk group...
Journal Articles
Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2025) 103 (3): 253–263.
Published Online: 26 August 2024
... of IRS-1 expression were associated with poor prognosis and increased lymph node metastasis. [email protected] 16 05 2024 13 08 2024 26 08 2024 Data extraction was carried out by two authors which included the author name, year of publication, the methodology adopted...
Journal Articles
Identification and Initial Validation of Neuroendocrine Differentiation as a Novel Prognostic Factor in Stage II Colorectal Cancer Patients
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2025) 103 (2): 156–166.
Published Online: 19 August 2024
...Yu Liang; Yongmin Li; Rui Guo; Yan Zhao; Huanshuo Miao; Hong Chang; Yue Chen Introduction: Neuroendocrine differentiation is often found in colorectal cancer, but its impact on prognosis remains controversial. This study explored the association between neuroendocrine differentiation and prognosis...
Journal Articles
Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis
Available to PurchaseSubject Area:
Oncology
Franziska Maria Kraus, Alexander Traut, Georg Nilius, Jan Volmerig, Andreas Koziorowski, Imke Stöver, Florian Grabellus, Michael Stahl, Daniel C. Christoph
Journal:
Oncology
Oncology (2025) 103 (3): 179–191.
Published Online: 19 August 2024
...-/immunotherapy with an objective response rate (ORR) of 31.6% and a disease control rate of 57.9%. Median progression-free survival (PFS) and OS of PAED patients with systemic therapy were very poor (3.9 months and 5.9 months). Conclusions: Caucasian patients with TTF-1 negative PAED have a poor prognosis...
Journal Articles
High Expression of Cancer-Derived Sialylated Immunoglobulin G: A Novel Biomarker for Poor Prognosis in Laryngeal Squamous Cell Carcinoma
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2025) 103 (3): 227–236.
Published Online: 12 August 2024
...: Immunohistochemistry (IHC) was utilized to assess SIA-IgG expression in tumor samples from 75 LSCC patients, aiming to investigate its correlation with clinical prognosis. In vitro functional experiments were conducted to explore the impact of SIA-IgG expression on the proliferative and migratory abilities...
Journal Articles
Subject Area:
Oncology
Jingkai Zhou, Haihang Nie, Xiaoqiang Yang, Fan Wang, Panpan Yu, Yali Yu, Yumei Ning, Jun Lai, Haizhou Wang, Qiu Zhao, Fei Xu
Journal:
Oncology
Oncology (2024) 102 (12): 1041–1055.
Published Online: 24 July 2024
..., further research is needed to explore the influence of USP52 on the prognosis of colorectal cancer (CRC), the tumor immune microenvironment, and therapeutic response. Methods: The differential expression of USP52 between CRC and normal tissues was analyzed using multiple public databases. The relationship...
Journal Articles
Comprehensive Study of Chromosomal Copy Number Variations and Genomic Variations Predicting Overall Survival in Myelodysplastic Syndromes
Available to PurchaseSubject Area:
Oncology
Nehakumari Maurya, Chandrakala Shanmukhaiah, Somprakash Dhangar, Manisha Madkaikar, Babu Rao Vundinti
Journal:
Oncology
Oncology (2024) 102 (10): 897–906.
Published Online: 05 March 2024
... presented with frequent lesions and also with a more hazard ratio (2.7, 95% CI: 0.37–21) when analyzed by Kaplan-Meier survival analysis. Conclusion: CGH + SNP array changed the cytogenetic and IPSS-R risk group in 18% and 13% of patients, respectively, with an improved prediction of prognosis. This study...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2024) 102 (8): 710–719.
Published Online: 17 January 2024
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Lung Adenocarcinoma SGLT2 Surgery Prognosis Lung...
Journal Articles
Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal Cancer
Available to PurchaseSubject Area:
Oncology
Chengzeng Yin, Yoshinaga Okugawa, Takahito Kitajima, Tadanobu Shimura, Ruiya Ma, Mikio Kawamura, Shigeyuki Yoshiyama, Yoshiki Okita, Masaki Ohi, Yuji Toiyama
Journal:
Oncology
Oncology (2024) 102 (7): 556–564.
Published Online: 22 December 2023
... proportional hazards models and multivariable logistic regression were employed to identify independent risk factors of surgical site infection and prognosis. Results: Increased preoperative IBI significantly correlated with higher tumor stage. Patients with high IBI experienced shorter overall survival ( p...
Journal Articles
Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2024) 102 (5): 368–381.
Published Online: 12 October 2023
... of the cuproptosis-related gene γ-glutamylcysteine synthetase (GCSH) on the prognosis of endometrial cancer (EC), the tumor immune microenvironment, and therapeutic response. Methods: The differential expression of GCSH between EC and normal tissues was analyzed using multiple public databases. Additionally, cancer...
Journal Articles
Preoperative Radiotherapy Does Not Change the Existing Treatment Paradigm in Stage III Breast Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2024) 102 (4): 310–317.
Published Online: 25 September 2023
... does not improve OS in patients with stage III breast cancer and has a worse prognosis. Preoperative RT has not changed the existing treatment paradigm in the current therapeutic context for patients with stage III breast cancer. [email protected] 28 02 2023 23 08 2023 25 09...
Journal Articles
Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis
Available to PurchaseSubject Area:
Oncology
Bernhard Doleschal, Dora Niedersüß-Beke, Patrick Kirchweger, Andreas Petzer, Josef Thaler, Holger Rumpold
Journal:
Oncology
Oncology (2024) 102 (2): 107–113.
Published Online: 12 September 2023
..., instructions or products referred to in the content or advertisements. 2023 Chemotherapy Metastatic colorectal cancer Prognosis Early-onset metastatic colorectal cancer Advancements in local and systemic therapies, coupled with the implementation of screening colonoscopies, have contributed...
Journal Articles
Subject Area:
Oncology
Caterina Vivaldi, Virginia Genovesi, Clara Ugolini, Laura Bernardini, Andrea Casadei-Gardini, Vincenzo Formica, Francesca Salani, Giulia Orsi, Valentina Massa, Andrea Cacciato-Insilla, Miriam Caccese, Silvia Cesario, Kalliopi Andrikou, Jessica Graziani, Daniela Campani, Enrico Vasile, Gabriella Fontanini, Lorenzo Fornaro, Gianluca Masi
Journal:
Oncology
Oncology (2024) 102 (2): 157–167.
Published Online: 12 September 2023
...-BTCs patients. We identified MMR proficiency (pMMR)/deficiency (dMMR) according to the loss of MMR proteins (MLH1, PMS2, MSH2, MSH6). The primary objective of the study was to assess the incidence of dMMR in BTCs; the secondary purpose was to explore its association with prognosis and clinical features...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2024) 102 (2): 168–182.
Published Online: 12 September 2023
... a significant impact on the prognosis of patients with LGG only. In addition, in tumor microenvironment and tumor immune analysis, we found that the level of immune infiltration, tumor mutational load, microsatellite instability, and immune checkpoints of LGG were significantly correlated with SMG5 expression...
Journal Articles
Shadi Chamseddine, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu, Hop S. Tran Cao, Lianchun Xiao, Ryan Sun, Jeffrey S. Morris, Rikita I. Hatia, Manal Hassan, Dan G. Duda, Maria Diab, Amr Mohamed, Ahmed Nassar, Saumil Datar, Hesham M. Amin, Ahmed Omar Kaseb
Journal:
Oncology
Oncology (2023) 101 (11): 730–737.
Published Online: 23 August 2023
.... Consistent with published literature [ 9 ], our findings showed a poor prognosis for high circulating IL-8 levels in HCC patients, particularly in early-stage disease. © 2023 The Author(s). Published by S. Karger AG, Basel Open Access License / Drug Dosage / Disclaimer This article is licensed under...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2024) 102 (1): 43–52.
Published Online: 14 August 2023
... is a convenient and objective liver function evaluation index, which plays an important role in the prediction of patient survival rate and prognosis. Promoting the ALBI score in HCC can help doctors judge the patient’s condition and improve the diagnosis and precise treatment effect. Fig. 2. Cooperation...
1